Literature DB >> 19126777

Association of ESR1 gene tagging SNPs with breast cancer risk.

Alison M Dunning1, Catherine S Healey, Caroline Baynes, Ana-Teresa Maia, Serena Scollen, Ana Vega, Raquel Rodríguez, Nuno L Barbosa-Morais, Bruce A J Ponder, Yen-Ling Low, Sheila Bingham, Christopher A Haiman, Loic Le Marchand, Annegien Broeks, Marjanka K Schmidt, John Hopper, Melissa Southey, Matthias W Beckmann, Peter A Fasching, Julian Peto, Nichola Johnson, Stig E Bojesen, Børge Nordestgaard, Roger L Milne, Javier Benitez, Ute Hamann, Yon Ko, Rita K Schmutzler, Barbara Burwinkel, Peter Schürmann, Thilo Dörk, Tuomas Heikkinen, Heli Nevanlinna, Annika Lindblom, Sara Margolin, Arto Mannermaa, Veli-Matti Kosma, Xiaoqing Chen, Amanda Spurdle, Jenny Change-Claude, Dieter Flesch-Janys, Fergus J Couch, Janet E Olson, Gianluca Severi, Laura Baglietto, Anne-Lise Børresen-Dale, Vessela Kristensen, David J Hunter, Susan E Hankinson, Peter Devilee, Maaike Vreeswijk, Jolanta Lissowska, Louise Brinton, Jianjun Liu, Per Hall, Daehee Kang, Keun-Young Yoo, Chen-Yang Shen, Jyh-Cherng Yu, Hoda Anton-Culver, Argyrios Ziogoas, Alice Sigurdson, Jeff Struewing, Douglas F Easton, Montserrat Garcia-Closas, Manjeet K Humphreys, Jonathan Morrison, Paul D P Pharoah, Karen A Pooley, Georgia Chenevix-Trench.   

Abstract

We have conducted a three-stage, comprehensive single nucleotide polymorphism (SNP)-tagging association study of ESR1 gene variants (SNPs) in more than 55,000 breast cancer cases and controls from studies within the Breast Cancer Association Consortium (BCAC). No large risks or highly significant associations were revealed. SNP rs3020314, tagging a region of ESR1 intron 4, is associated with an increase in breast cancer susceptibility with a dominant mode of action in European populations. Carriers of the c-allele have an odds ratio (OR) of 1.05 [95% Confidence Intervals (CI) 1.02-1.09] relative to t-allele homozygotes, P = 0.004. There is significant heterogeneity between studies, P = 0.002. The increased risk appears largely confined to oestrogen receptor-positive tumour risk. The region tagged by SNP rs3020314 contains sequence that is more highly conserved across mammalian species than the rest of intron 4, and it may subtly alter the ratio of two mRNA splice forms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19126777      PMCID: PMC2722230          DOI: 10.1093/hmg/ddn429

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease.

Authors:  P Zuppan; J M Hall; M K Lee; M Ponglikitmongkol; M C King
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.

Authors:  Alisa D Kjaergaard; Christina Ellervik; Anne Tybjaerg-Hansen; Christen Kirk Axelsson; Marie-Louise M Grønholdt; Peer Grande; Gorm B Jensen; Børge G Nordestgaard
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

3.  Estrogen receptor genotypes and haplotypes associated with breast cancer risk.

Authors:  Bert Gold; Francis Kalush; Julie Bergeron; Kevin Scott; Nandita Mitra; Kelly Wilson; Nathan Ellis; Helen Huang; Michael Chen; Ross Lippert; Bjarni V Halldorsson; Beth Woodworth; Thomas White; Andrew G Clark; Fritz F Parl; Samuel Broder; Michael Dean; Kenneth Offit
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

4.  Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.

Authors:  S M Hill; S A Fuqua; G C Chamness; G L Greene; W L McGuire
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

5.  Estrogen receptor polymorphism predicts the onset of natural and surgical menopause.

Authors:  A E Weel; A G Uitterlinden; I C Westendorp; H Burger; S C Schuit; A Hofman; T J Helmerhorst; J P van Leeuwen; H A Pols
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

6.  Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution.

Authors:  T Okura; M Koda; F Ando; N Niino; S Ohta; H Shimokata
Journal:  Int J Obes Relat Metab Disord       Date:  2003-09

7.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Authors:  S A Fuqua; S D Fitzgerald; G C Chamness; A K Tandon; D P McDonnell; Z Nawaz; B W O'Malley; W L McGuire
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study.

Authors:  L P Fernández; R L Milne; E Barroso; M Cuadros; J I Arias; A Ruibal; J Benítez; G Ribas
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

9.  Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction.

Authors:  Stephanie C E Schuit; Hok-Hay S Oei; Jacqueline C M Witteman; Corine H Geurts van Kessel; Joyce B J van Meurs; Rogier L Nijhuis; Johannes P T M van Leeuwen; Frank H de Jong; M Carola Zillikens; Albert Hofman; Huibert A P Pols; André G Uitterlinden
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

10.  ESR1 and EGF genetic variation in relation to breast cancer risk and survival.

Authors:  Kristjana Einarsdóttir; Hatef Darabi; Yi Li; Yen Ling Low; Yu Qing Li; Carine Bonnard; Arvid Sjölander; Kamila Czene; Sara Wedrén; Edison T Liu; Per Hall; Keith Humphreys; Jianjun Liu
Journal:  Breast Cancer Res       Date:  2008-02-14       Impact factor: 6.466

View more
  51 in total

1.  Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer.

Authors:  Chan Xiang; Haidong Gao; Lei Meng; Zhaoyu Qin; Rong Ma; Yang Liu; Yan Jiang; Chengxue Dang; Li Jin; Fuchu He; Haijian Wang
Journal:  Cancer Sci       Date:  2012-04-12       Impact factor: 6.716

Review 2.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

3.  Polymorphisms in the gene encoding estrogen receptor alpha are associated with osteoarthritis in Han Chinese women.

Authors:  Wei Liu; Feng-Min Shao; Lei Yan; Hui-Xia Cao; Dong Qiu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

Authors:  Alison M Dunning; Kyriaki Michailidou; Karoline B Kuchenbaecker; Deborah Thompson; Juliet D French; Jonathan Beesley; Catherine S Healey; Siddhartha Kar; Karen A Pooley; Elena Lopez-Knowles; Ed Dicks; Daniel Barrowdale; Nicholas A Sinnott-Armstrong; Richard C Sallari; Kristine M Hillman; Susanne Kaufmann; Haran Sivakumaran; Mahdi Moradi Marjaneh; Jason S Lee; Margaret Hills; Monika Jarosz; Suzie Drury; Sander Canisius; Manjeet K Bolla; Joe Dennis; Qin Wang; John L Hopper; Melissa C Southey; Annegien Broeks; Marjanka K Schmidt; Artitaya Lophatananon; Kenneth Muir; Matthias W Beckmann; Peter A Fasching; Isabel Dos-Santos-Silva; Julian Peto; Elinor J Sawyer; Ian Tomlinson; Barbara Burwinkel; Frederik Marme; Pascal Guénel; Thérèse Truong; Stig E Bojesen; Henrik Flyger; Anna González-Neira; Jose I A Perez; Hoda Anton-Culver; Lee Eunjung; Volker Arndt; Hermann Brenner; Alfons Meindl; Rita K Schmutzler; Hiltrud Brauch; Ute Hamann; Kristiina Aittomäki; Carl Blomqvist; Hidemi Ito; Keitaro Matsuo; Natasha Bogdanova; Thilo Dörk; Annika Lindblom; Sara Margolin; Veli-Matti Kosma; Arto Mannermaa; Chiu-Chen Tseng; Anna H Wu; Diether Lambrechts; Hans Wildiers; Jenny Chang-Claude; Anja Rudolph; Paolo Peterlongo; Paolo Radice; Janet E Olson; Graham G Giles; Roger L Milne; Christopher A Haiman; Brian E Henderson; Mark S Goldberg; Soo H Teo; Cheng Har Yip; Silje Nord; Anne-Lise Borresen-Dale; Vessela Kristensen; Jirong Long; Wei Zheng; Katri Pylkäs; Robert Winqvist; Irene L Andrulis; Julia A Knight; Peter Devilee; Caroline Seynaeve; Jonine Figueroa; Mark E Sherman; Kamila Czene; Hatef Darabi; Antoinette Hollestelle; Ans M W van den Ouweland; Keith Humphreys; Yu-Tang Gao; Xiao-Ou Shu; Angela Cox; Simon S Cross; William Blot; Qiuyin Cai; Maya Ghoussaini; Barbara J Perkins; Mitul Shah; Ji-Yeob Choi; Daehee Kang; Soo Chin Lee; Mikael Hartman; Maria Kabisch; Diana Torres; Anna Jakubowska; Jan Lubinski; Paul Brennan; Suleeporn Sangrajrang; Christine B Ambrosone; Amanda E Toland; Chen-Yang Shen; Pei-Ei Wu; Nick Orr; Anthony Swerdlow; Lesley McGuffog; Sue Healey; Andrew Lee; Miroslav Kapuscinski; Esther M John; Mary Beth Terry; Mary B Daly; David E Goldgar; Saundra S Buys; Ramunas Janavicius; Laima Tihomirova; Nadine Tung; Cecilia M Dorfling; Elizabeth J van Rensburg; Susan L Neuhausen; Bent Ejlertsen; Thomas V O Hansen; Ana Osorio; Javier Benitez; Rachel Rando; Jeffrey N Weitzel; Bernardo Bonanni; Bernard Peissel; Siranoush Manoukian; Laura Papi; Laura Ottini; Irene Konstantopoulou; Paraskevi Apostolou; Judy Garber; Muhammad Usman Rashid; Debra Frost; Louise Izatt; Steve Ellis; Andrew K Godwin; Norbert Arnold; Dieter Niederacher; Kerstin Rhiem; Nadja Bogdanova-Markov; Charlotte Sagne; Dominique Stoppa-Lyonnet; Francesca Damiola; Olga M Sinilnikova; Sylvie Mazoyer; Claudine Isaacs; Kathleen B M Claes; Kim De Leeneer; Miguel de la Hoya; Trinidad Caldes; Heli Nevanlinna; Sofia Khan; Arjen R Mensenkamp; Maartje J Hooning; Matti A Rookus; Ava Kwong; Edith Olah; Orland Diez; Joan Brunet; Miquel Angel Pujana; Jacek Gronwald; Tomasz Huzarski; Rosa B Barkardottir; Rachel Laframboise; Penny Soucy; Marco Montagna; Simona Agata; Manuel R Teixeira; Sue Kyung Park; Noralane Lindor; Fergus J Couch; Marc Tischkowitz; Lenka Foretova; Joseph Vijai; Kenneth Offit; Christian F Singer; Christine Rappaport; Catherine M Phelan; Mark H Greene; Phuong L Mai; Gad Rennert; Evgeny N Imyanitov; Peter J Hulick; Kelly-Anne Phillips; Marion Piedmonte; Anna Marie Mulligan; Gord Glendon; Anders Bojesen; Mads Thomassen; Maria A Caligo; Sook-Yee Yoon; Eitan Friedman; Yael Laitman; Ake Borg; Anna von Wachenfeldt; Hans Ehrencrona; Johanna Rantala; Olufunmilayo I Olopade; Patricia A Ganz; Robert L Nussbaum; Simon A Gayther; Katherine L Nathanson; Susan M Domchek; Banu K Arun; Gillian Mitchell; Beth Y Karlan; Jenny Lester; Gertraud Maskarinec; Christy Woolcott; Christopher Scott; Jennifer Stone; Carmel Apicella; Rulla Tamimi; Robert Luben; Kay-Tee Khaw; Åslaug Helland; Vilde Haakensen; Mitch Dowsett; Paul D P Pharoah; Jacques Simard; Per Hall; Montserrat García-Closas; Celine Vachon; Georgia Chenevix-Trench; Antonis C Antoniou; Douglas F Easton; Stacey L Edwards
Journal:  Nat Genet       Date:  2016-02-29       Impact factor: 38.330

5.  Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods.

Authors:  Lothar Häberle; Alexander Hein; Matthias Rübner; Michael Schneider; Arif B Ekici; Paul Gass; Arndt Hartmann; Rüdiger Schulz-Wendtland; Matthias W Beckmann; Wing-Yee Lo; Werner Schroth; Hiltrud Brauch; Peter A Fasching; Marius Wunderle
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-06-28       Impact factor: 2.915

6.  Genome-wide association studies in cancer--current and future directions.

Authors:  Charles C Chung; Wagner C S Magalhaes; Jesus Gonzalez-Bosquet; Stephen J Chanock
Journal:  Carcinogenesis       Date:  2009-11-11       Impact factor: 4.944

7.  Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Authors:  Yen Ling Low; Yuqing Li; Keith Humphreys; Anbupalam Thalamuthu; Yi Li; Hatef Darabi; Sara Wedrén; Carine Bonnard; Kamila Czene; Mark M Iles; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna; Per Hall; Edison T Liu; Jianjun Liu
Journal:  PLoS Genet       Date:  2010-07-01       Impact factor: 5.917

8.  Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.

Authors:  Núria Bonifaci; Bohdan Górski; Bartlomiej Masojć; Dominika Wokołorczyk; Anna Jakubowska; Tadeusz Dębniak; Antoni Berenguer; Jordi Serra Musach; Joan Brunet; Joaquín Dopazo; Steven A Narod; Jan Lubiński; Conxi Lázaro; Cezary Cybulski; Miguel Angel Pujana
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

9.  ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.

Authors:  Brian Leyland-Jones; Kathryn P Gray; Mark Abramovitz; Mark Bouzyk; Brandon Young; Bradley Long; Roswitha Kammler; Patrizia Dell'Orto; Maria Olivia Biasi; Beat Thürlimann; Vernon Harvey; Patrick Neven; Laurent Arnould; Rudolf Maibach; Karen N Price; Alan S Coates; Aron Goldhirsch; Richard D Gelber; Olivia Pagani; Giuseppe Viale; James M Rae; Meredith M Regan
Journal:  Breast Cancer Res Treat       Date:  2015-11-21       Impact factor: 4.872

10.  Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.

Authors:  Ryan J Hartmaier; Sandrine Tchatchou; Alexandra S Richter; Jay Wang; Sean E McGuire; Todd C Skaar; Jimmy M Rae; Kari Hemminki; Christian Sutter; Nina Ditsch; Peter Bugert; Bernhard H F Weber; Dieter Niederacher; Norbert Arnold; Raymonda Varon-Mateeva; Barbara Wappenschmidt; Rita K Schmutzler; Alfons Meindl; Claus R Bartram; Barbara Burwinkel; Steffi Oesterreich
Journal:  BMC Cancer       Date:  2009-12-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.